EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Strength of CAR signaling determines T cell versus ILC differentiation from pluripotent stem cells

Suwen Li, Chloe S Wang, Amélie Montel-Hagen, Ho-Chung Chen, Shawn Lopez, Olivia Zhou, Kristy Dai, Steven Tsai, William Satyadi, Carlos Botero, Claudia Wong, David Casero und 2 weitere

Cell Reports · 2023

DOI: 10.1016/j.celrep.2023.112241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Suwen Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine (DGSOM), University of California, Los Angeles, Los Angeles,…. Hauptthemen laut MEDLINE: T-Lymphocytes, Pluripotent Stem Cells. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS, V Foundation for Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Generation of chimeric antigen receptor (CAR) T cells from pluripotent stem cells (PSCs) will enable advances in cancer immunotherapy. Understanding how CARs affect T cell differentiation from PSCs is important for this effort. The recently described artificial thymic organoid (ATO) system supports in vitro differentiation of PSCs to T cells. Unexpectedly, PSCs transduced with a CD19-targeted CAR resulted in diversion of T cell differentiation to the innate lymphoid cell 2 (ILC2) lineage in ATOs. T cells and ILC2s are closely related lymphoid lineages with shared developmental and transcriptional programs. Mechanistically, we show that antigen-independent CAR signaling during lymphoid development enriched for ILC2-primed precursors at the expense of T cell precursors. We applied this understanding to modulate CAR signaling strength through expression level, structure, and presentation of cognate antigen to demonstrate that the T cell-versus-ILC lineage decision can be rationally controlled in either direction, providing a framework for achieving CAR-T cell development from PSCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-LymphocytesPluripotent Stem CellsImmunity, InnateLymphocytesCell DifferentiationImmunotherapy, AdoptiveAntigens, CD19Receptors, Antigen, T-Cell

Stichwörter der Autor:innen

CP: ImmunologyCP: Stem cell researchT cell developmentadoptive cell therapycancer immunotherapychimeric antigen receptorinnate lymphoid cellspluripotent stem cells

Substanzen

Antigens, CD19Receptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine (DGSOM), University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Pathology and Laboratory Medicine, David…
  • Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine (DGSOM), University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Pediatrics, David Geffen School of Medicine, University…
  • Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine (DGSOM), University of California, Los Angeles, Los Angeles, CA 90095, USA; Broad Stem Cell Research Center (BSCRC), David Geffen…

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS
  • V Foundation for Cancer Research
  • Tobacco-Related Disease Research Program
  • Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles
  • California Institute for Regenerative Medicine
  • National Institutes of Health

Zitieren

APA

Li, S., Wang, C. S., Montel-Hagen, A., Chen, H. C., Lopez, S., Zhou, O., Dai, K., Tsai, S., Satyadi, W., Botero, C., Wong, C., Casero, D., Crooks, G. M., & Seet, C. S. (2023). Strength of CAR signaling determines T cell versus ILC differentiation from pluripotent stem cells. Cell Reports. https://doi.org/10.1016/j.celrep.2023.112241

Vancouver

Li S, Wang CS, Montel-Hagen A, Chen HC, Lopez S, Zhou O, et al. Strength of CAR signaling determines T cell versus ILC differentiation from pluripotent stem cells. Cell Reports. 2023. doi:10.1016/j.celrep.2023.112241

BibTeX
@article{Li2023,
  author = {Li, Suwen and Wang, Chloe S and Montel-Hagen, Amélie and Chen, Ho-Chung and Lopez, Shawn and Zhou, Olivia and Dai, Kristy and Tsai, Steven and Satyadi, William and Botero, Carlos and Wong, Claudia and Casero, David and Crooks, Gay M and Seet, Christopher S},
  title = {Strength of CAR signaling determines T cell versus ILC differentiation from pluripotent stem cells},
  journal = {Cell Reports},
  year = {2023},
  doi = {10.1016/j.celrep.2023.112241}
}
Kostenlos starten →